Retail sale of pharmaceutical products
LUQMAN HOLDING AS
Revenue 2024
NOK 0
Operating profit
NOK −35,000
Equity
NOK 166,000
Incorporated
2020
Share capital
NOK 560,000
Key figures · 2024
Current ratio
1.09
Equity ratio
5.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -1.1% | |
| Likviditet | ||
| Current ratio | 1.09 | |
| Working capital | 2k | |
| Soliditet | ||
| Equity ratio (%%) | 5.3% | |
| Debt-to-equity ratio | 17.93 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.